Literature DB >> 7520857

Management of HIV-related bodyweight loss.

J H Von Roenn1.   

Abstract

Involuntary bodyweight loss is a frequent manifestation of HIV infection and ultimately affects the majority of patients. Because it portends a poor prognosis and adversely affects quality of life, nutritional intervention has an important role in the care of all HIV-infected persons. The mechanism of HIV-related bodyweight loss is multifactorial and includes complex interactions between decreased caloric intake, malabsorption and metabolic and/or hormonal abnormalities. Treatment of reversible and identifiable causes of bodyweight loss such as opportunistic infections and adverse effects of therapy are essential for the maintenance of bodyweight. For patients with anorexia of unclear aetiology, there are effective appetite stimulants available. Enteral and parenteral alimentation are under evaluation for their role in maintenance and/or repletion of bodyweight for patients with HIV infection.

Entities:  

Mesh:

Year:  1994        PMID: 7520857     DOI: 10.2165/00003495-199447050-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  21 in total

1.  Dronabinol effects on weight in patients with HIV infection.

Authors:  R Gorter; M Seefried; P Volberding
Journal:  AIDS       Date:  1992-01       Impact factor: 4.177

2.  Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases.

Authors: 
Journal:  MMWR Suppl       Date:  1987-08-14

3.  Incidence of malnutrition in patients with acquired immunodeficiency syndrome.

Authors:  L Chelluri; M S Jastremski
Journal:  Nutr Clin Pract       Date:  1989-02       Impact factor: 3.080

4.  Megestrol acetate for treatment of cachexia associated with human immunodeficiency virus (HIV) infection.

Authors:  J H von Roenn; R L Murphy; K M Weber; L M Williams; S A Weitzman
Journal:  Ann Intern Med       Date:  1988-11-15       Impact factor: 25.391

5.  A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer.

Authors:  E Bruera; K Macmillan; N Kuehn; J Hanson; R N MacDonald
Journal:  Cancer       Date:  1990-09-15       Impact factor: 6.860

6.  Effect of home total parenteral nutrition on body composition in patients with acquired immunodeficiency syndrome.

Authors:  D P Kotler; A R Tierney; J A Culpepper-Morgan; J Wang; R N Pierson
Journal:  JPEN J Parenter Enteral Nutr       Date:  1990 Sep-Oct       Impact factor: 4.016

7.  HIV wasting syndrome in the United States.

Authors:  B L Nahlen; S Y Chu; O C Nwanyanwu; R L Berkelman; S A Martinez; J V Rullan
Journal:  AIDS       Date:  1993-02       Impact factor: 4.177

Review 8.  Nutritional management of patients with ARC or AIDS.

Authors:  M S Hickey; K E Weaver
Journal:  Gastroenterol Clin North Am       Date:  1988-09       Impact factor: 3.806

Review 9.  NIH conference. Gastrointestinal infections in AIDS.

Authors:  P D Smith; T C Quinn; W Strober; E N Janoff; H Masur
Journal:  Ann Intern Med       Date:  1992-01-01       Impact factor: 25.391

10.  Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms.

Authors:  J A Nelson; C A Wiley; C Reynolds-Kohler; C E Reese; W Margaretten; J A Levy
Journal:  Lancet       Date:  1988-02-06       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.